International Association for the Study of Lung Cancer

The only global multidisciplinary network dedicated to lung cancer, uniting oncologists, scientists, nurses, pathologists, and patient advocates around research, two journals, a world congress, and the staging system that sets the field's shared standard

51named by IASLC
147named by peers

Financial profile

International Association for the Study of Lung Cancer · EIN 20-0499338 · 501(c)(3)

Fiscal yearTotal revenueContributionsProgram servicesTotal expensesNet assetsYear end
FY2023$24,616,047$1,166,332$22,918,096$20,136,070$20,864,393Dec 2023
FY2022$11,551,380$790,597$16,694,390$14,627,829$15,183,918Dec 2022
FY2021$13,685,313$2,374,814$12,626,237$11,754,042$17,206,958Dec 2021
FY2020$6,883,020$632,870$6,170,619$10,088,011$12,759,272Dec 2020
FY2019$18,805,451$836,129$16,912,007$17,830,693$15,046,639Dec 2019
FY2018$14,022,444$763,425$13,551,881$14,492,345$14,317,953Dec 2018

Figures exactly as reported. A blank cell was blank on the form. The fiscal year links to the filing.

Something wrong here? Tell us what we missed.

Peer societies

Five societies International Association for the Study of Lung Cancer is read alongside.

Who backs IASLC

Every company International Association for the Study of Lung Cancer names publicly as a supporter, exactly as published. Companies also named by other associations on Sociogene come first.

CompanySupport as publishedAlso named by
AbbVieCorporate partnerAND AAD AAN AAO AAPMR +3
AmgenCorporate partnerAAAAI AAFP AAN AAO AAPA +3
AstraZenecaCorporate partnerAMCP AAAAI AAFP AAN AAPA +3
BayerCorporate partnerAMCP AAAAI AAFP AAN AAPA +3
Boehringer IngelheimCorporate partnerAAD AAFP AAO AAPA AACR +3
Bristol Myers SquibbCorporate partnerAMCP ARM AAD AAN AAPMR +3
Corp_Rel_Merck_LogoCorporate partnerAAFP AAO AAP AAPA AAM +3
Daiichi - SankyoCorporate partnerAACR ACS AOSSM ASCO ASH +3
Eisai.pngMeeting sponsorAMCP AAFP AAN AAPA AASM +3
Gilead and Kite OncologyCorporate partnerAMCP AAPA AASLD ACG ACOG +3
GSK.pngMeeting sponsorAMCP AAAAI AAO AAPA AACR +3
IntuitiveExhibitorAATS AAGL ACCP ACHE ASTS +3
Johnson & JohnsonCorporate partnerAMCP ACS AAD AAFP AAN +3
Lilly_Sponsor_Partner_LogoCorporate partnerAND AWMA AAAP AAA AAD +3
MDPIExhibitorACS AAR APHA ASV ASHG +3
NateraExhibitorAASLD AATS AAES ACNM ACOG +3
Patient_Adv_Genentech-LogoCorporate partnerAMCP AAAAI AAFP AAN AAO +3
PfizerCorporate partnerASCA AAD AAFP AAN AAP +3
RegeneronCorporate partnerAAAAI AAD AAP AACR AASLD +3
Roche.pngMeeting sponsorAAN ASM ASV ASCO ASH +3
Siemens.pngMeeting sponsorASCA AARC AASLD AAPIM ACCP +3
TakedaCorporate partnerAND AAAAI AAD AAFP AAN +3
Thermo-Fisher-Scientific-2.pngMeeting sponsorARM AASLD AAI AAPS ACR +3
ParexelExhibitorARM ACR ASGCT ACRO ACRP +2
Guardant.pngMeeting sponsorAAFP ACS AMP CAP COA +1
Revolution MedicineCorporate partnerAACR ASCO AMP CAP COA +1
BeOne.pngMeeting sponsorAMCP ASA COA CCFAS SHO
Caris Life SciencesExhibitorAMP CAP COA MRS
Foundation MedicineExhibitorAMP COA GSAFC MRA
Integrated DNA Technologies (IDT)ExhibitorASHG AMP ACRP GICI
Scanlan InternationalExhibitorACS AATS CNS STS
BioNTechCorporate partnerASCO COA CCFAS
MSD.pngMeeting sponsorISID WSPID
NuvalentCorporate partnerAACR COA
PharmacosmosExhibitorAASV COA
PharmaMarExhibitorASCO CCFAS
Qure.aiExhibitorAATS ACCP
CORELINEExhibitorRSNA
ImmunityBioExhibitorSUO
Inocras, Inc.ExhibitorAMP
Merck.png (linked to merckgroup.com)Meeting sponsorIUPAC
Nuvation-Bio.pngMeeting sponsorCOA
Razor GenomicsExhibitorAATS
Abion Inc.ExhibitorOnly International Association for the Study of Lung Cancer, so far
AME Publishing CompanyExhibitorOnly International Association for the Study of Lung Cancer, so far
IMBdxExhibitorOnly International Association for the Study of Lung Cancer, so far
JNPMEDIExhibitorOnly International Association for the Study of Lung Cancer, so far
Noah AIExhibitorOnly International Association for the Study of Lung Cancer, so far
Oncology FrontierExhibitorOnly International Association for the Study of Lung Cancer, so far
Plusman LLCExhibitorOnly International Association for the Study of Lung Cancer, so far
Summit Therapeutics Inc.ExhibitorOnly International Association for the Study of Lung Cancer, so far
Sources: 3 published lists, read September 2026

IASLC Partners for Thoracic Cancer Care: Current Gold and Silver Partners. Read September 27, 2026. Corporate partner program; names from logo alt text.

WCLC 2026 Confirmed Exhibitors. Read September 27, 2026. WCLC 2026 exhibitors; associations, patient groups, foundations and tourism bodies left out.

WCLC 2026 Confirmed Industry Supporters. Read September 27, 2026. World Conference on Lung Cancer 2026 supporters; names from logo file names and linked sites. BMS Foundation and destination supporters (Seoul Tourism Organization, Korea Tourism Organization) left out.

Something wrong here? Tell us what we missed.

Who backs International Association for the Study of Lung Cancer's peers, but not International Association for the Study of Lung Cancer

Companies named publicly by at least one of International Association for the Study of Lung Cancer's five peer societies, and not found in International Association for the Study of Lung Cancer's reviewed public records.

CompanyASCOAACRSICASROSSOPeers
NovartisPlatinumStrategic Sustaining MembersCorporate Advisory Council MembersNamed4 of 5
AstellasLeadership Sustaining MembersCorporate Advisory Council MembersNamed3 of 5
Gilead KiteSilverLeadership Sustaining MembersCorporate Advisory Council Members3 of 5
LillySilverLeadership Sustaining MembersNamed3 of 5
NovocureAdvocateMajor Sustaining MembersNamed3 of 5
BeOneAdvocateMajor Sustaining Members2 of 5
Boston ScientificNamedSilver2 of 5
Coherus OncologyAdvocateNamed2 of 5
Exact Sciences CorporationBronzeNamed2 of 5
Exelixis, Inc.BronzeMajor Sustaining Members2 of 5
GenmabMajor Sustaining MembersStandard Corporate Members2 of 5
HELSINNSilverNamed2 of 5
Hologic, Inc.NamedNamed2 of 5
IovanceStandard Corporate MembersGold2 of 5
IpsenMajor Sustaining MembersStandard Corporate Members2 of 5
LantheusAdvocateNamed2 of 5
SanofiMajor Sustaining MembersNamed2 of 5
Abbott LaboratoriesNamed1 of 5
AccessHopeNamed1 of 5
AccurayNamed1 of 5
AduroNamed1 of 5
AkesisNamed1 of 5
Alliance OncologyNamed1 of 5
Allos TherapeuticsNamed1 of 5
American Medical Accounting and Consulting (AMAC)Named1 of 5
BardNamed1 of 5
Bayer Healthcare (formerly Berlex)Named1 of 5
Beijing HGPT Technology & TradeNamed1 of 5
Best Medical InternationalNamed1 of 5
BiogenNamed1 of 5
BioProtectNamed1 of 5
Blue Earth DiagnosticsNamed1 of 5
BrainLabNamed1 of 5
BSD MedicalNamed1 of 5
ByondisAssociate Sustaining members1 of 5
C-RADNamed1 of 5
CanonNamed1 of 5
Carestream HealthNamed1 of 5
Carl Zeiss Meditec Inc.Named1 of 5
CastleGold1 of 5
Castle Biosciences, Inc.Named1 of 5
CDR SystemsNamed1 of 5
CelgeneNamed1 of 5
Cellectar BiosciencesNamed1 of 5
Chimerix Inc.Named1 of 5
Color Health Inc.Named1 of 5
CordisNamed1 of 5
CQ MedicalNamed1 of 5
CytogenNamed1 of 5
DepomedNamed1 of 5
ElektaNamed1 of 5
Elevar TherapeuticsNamed1 of 5
Elsevier Clinical PathNamed1 of 5
EMD Serono, Inc.Named1 of 5
Empyrean Medical Systems Inc.Named1 of 5
Epiphany Partners Inc.Named1 of 5
ES-AbbottMajor Sustaining Members1 of 5
Flatiron Health, Inc.Named1 of 5
Galera TherapeuticsNamed1 of 5
GammaTileNamed1 of 5
GE HealthCareNamed1 of 5
GenesisCareNamed1 of 5
Gilead and Kite OncologyPromise Level1 of 5
Gold AnchorNamed1 of 5
GPC BiotechNamed1 of 5
GrailAssociate Sustaining members1 of 5
GuardantAssociate Sustaining members1 of 5
HarborsideNamed1 of 5
HistosonicsGold1 of 5
Hitachi, Ltd.Named1 of 5
IBANamed1 of 5
IlluminaNamed1 of 5
ImCloneNamed1 of 5
IncyteStrategic Sustaining Members1 of 5
Inhibrx Biosciences, Inc.Named1 of 5
Integra LifeSciencesNamed1 of 5
IntraOpNamed1 of 5
IsoRay MedicalNamed1 of 5
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals)Named1 of 5
KiteCorporate Advisory Council Members1 of 5
Kura OncologyNamed1 of 5
LAPNamed1 of 5
Loxo Oncology Inc., a wholly owned subsidiary of Eli Lilly and CompanyNamed1 of 5
Macromedics BVNamed1 of 5
MEDA PharamceuticalsNamed1 of 5
MevionNamed1 of 5
MillenniumNamed1 of 5
MIM Software Inc.Named1 of 5
Mirada MedicalNamed1 of 5
ModernaNamed1 of 5
Myovant Sciences Inc.Named1 of 5
Myriad GeneticsNamed1 of 5
NanobiotixNamed1 of 5
Naveris Inc.Named1 of 5
New Rhein Healthcare, LLCNamed1 of 5
North American ScientificNamed1 of 5
NorthStar Medical RadioisotopesNamed1 of 5
NovosteNamed1 of 5
NurixAssociate Sustaining members1 of 5
Oncology Services InternationalNamed1 of 5
OncuraNamed1 of 5
Ortho BiotechNamed1 of 5
P-Cure Ltd.Named1 of 5
Palette Life SciencesNamed1 of 5
Parse BiosciencesPromise Level1 of 5
Perspective TherapeuticsNamed1 of 5
PhilipsNamed1 of 5
PMVAssociate Sustaining members1 of 5
PreludeDxNamed1 of 5
ProTechSureNamed1 of 5
Provision HealthCareNamed1 of 5
QFixNamed1 of 5
RAD Technology Medical SystemsNamed1 of 5
Radformation Inc.Named1 of 5
RadiadyneNamed1 of 5
Radiation Business SolutionsNamed1 of 5
RaySearch LaboratoriesNamed1 of 5
RefleXionNamed1 of 5
ReplimueStandard Corporate Members1 of 5
Sarah Cannon Research InstituteNamed1 of 5
ScandiDosNamed1 of 5
SeagenNamed1 of 5
Sensus HealthCareNamed1 of 5
Servier PharmaceuticalsNamed1 of 5
SirtexNamed1 of 5
SpectrumNamed1 of 5
SpringWorks Therapeutics Inc.Advocate1 of 5
Stemline, Inc, a Menarini Group CompanyNamed1 of 5
Sun Nuclear CorporationNamed1 of 5
Sun PharmaStandard Corporate Members1 of 5
SyndaxMajor Sustaining Members1 of 5
Syndax Pharmaceuticals, Inc.Named1 of 5
TAE Life SciencesNamed1 of 5
TAIHO Oncology, Inc.Innovator1 of 5
Telix PharmaceuticalsNamed1 of 5
TheragenicsNamed1 of 5
TherapanaceaNamed1 of 5
Vaniam Group LLCNamed1 of 5
VeracyteNamed1 of 5
Verastem-OncologyAssociate Sustaining members1 of 5
Vertual LTD.Named1 of 5
ViewRay SystemsNamed1 of 5
Vision RTNamed1 of 5
VOXIMETRYNamed1 of 5
Women Leaders in Oncology LLC and Deanna van GestelNamed1 of 5
XstrahlNamed1 of 5
ZaiAssociate Sustaining members1 of 5

Something wrong here? Tell us what we missed.

The outside view

The only global multidisciplinary network dedicated to lung cancer, uniting oncologists, scientists, nurses, pathologists, and patient advocates around research, two journals, a world congress, and the staging system that sets the field's shared standard

  • Consensus
  • Build
  • Outward
  • Operational

Their shape

The Republic

Run by its members, built to outlast them.

The Republic runs like a well-built institution, professional and stable, under the guidance of its members. Its gift is scale and continuity, its challenge is staying close to the grassroots as it grows.

Also reads toward The Citadel and The Movement.

Strengths

→Member voice and public mission stay in healthy balance.
→Open to reform without losing its footing.
→Speaks credibly on behalf of a whole field.

Not an official page of International Association for the Study of Lung Cancer. Sociogene does not consult. Everything here comes from public sources, dated and linked. Something wrong here? Tell us what we missed.